Compare KELYA & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KELYA | NPCE |
|---|---|---|
| Founded | 1946 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.2M | 490.2M |
| IPO Year | 1994 | 2021 |
| Metric | KELYA | NPCE |
|---|---|---|
| Price | $13.76 | $12.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $20.00 | $20.00 |
| AVG Volume (30 Days) | ★ 296.0K | 97.8K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ 0.10 | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | N/A | $0.36 |
| Revenue Next Year | $3.70 | $22.05 |
| P/E Ratio | $112.73 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $7.98 | $12.00 |
| 52 Week High | $17.75 | $19.60 |
| Indicator | KELYA | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 31.28 | 43.15 |
| Support Level | $8.79 | N/A |
| Resistance Level | $16.61 | $15.26 |
| Average True Range (ATR) | 0.79 | 0.65 |
| MACD | -0.23 | 0.02 |
| Stochastic Oscillator | 8.70 | 19.33 |
Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.